Global Alert and Response (GAR)

WHO infection control guidelines for transmissible spongiform encephalopathies. Report of a WHO consultation, Geneva, Switzerland, 23-26 March 1999

WHO/CDS/CSR/APH/2000/3

Download Document


WHO Infection Control Guidelines for Transmissible Spongiform Encephalopathies. Report of a WHO Consultation, Geneva, Switzerland, 23-26 March 1999

Section 1  Introduction
Section 2  General Considerations
     2.1      Transmissible Spongiform Encephalopathies in Humans and in Animals
     2.2      Diagnosis of Human Transmissible Spongiform Encephalopathies
     2.3      Iatrogenic Transmission 
     2.4      Evaluating Risk in Healthcare Environments
Section 3  Patient Care
    3.1       Care of Patients in the Home and Healthcare Settings
    3.2        Dental Procedures
    3.3        Diagnostic Procedures
    3.4        Surgical Procedures
    3.5        Handling of Surgical Instruments
    3.6        Anaesthesia
    3.7        Pregnancy and Childbirth  
Section 4   Occupational Injury
    4.1        Occupational Exposure
    4.2        Post-exposure Management
Section 5   Laboratory Investigations
    5.1        Safety in the Healthcare Laboratory
    5.2        Clinical Diagnostic Laboratories
    5.3        Surgical Pathology
    5.4        Transport of Specimens by Air
Section 6   Decontamination Procedures
    6.1        General Considerations
    6.2         Decontamination of Instruments
    6.3        Decontamination of Work Surfaces
    6.4        Decontamination of Wastes and Waste-contaminated Materials
    6.5        Personal Protection During Decontamination Procedures 
    6.6        Decontamination Risk Categories  
Section 7   Waster Disposal
Section 8   After Death
     8.1       Precautions for Handling of the Deceased Patient
     8.2       Post Mortem Examination
     8.3       National and International Transport of Bodies
     8.4       Undertakers and Embalmers
     8.5       Funerals and Cremations
     8.6       Exhumations
     8.7       Body Donation for Teaching Purposes 
Annex 1    List of Participants
Annex 2    List of Presentations
Annex 3    Decontamination Methods for Transmissible Spongiform Encephalopathies
Annex 4    Management of Healthy 'At Risk' Individuals
Annex 5    Management of Individuals with Confirmed or Suspected Variant   Creutzfeldt-Jakob Disease

Share